Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Centhaquine in Hypovolemic Shock
NCT04056065Phase 2Completed
- Sponsor
- Pharmazz, Inc.
- Start
- May 2017
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of centhaquine in hypovolemic shock, sponsored by Pharmazz, Inc.. Started May 2017; status: completed.
02
Drugs
centhaquine
03
Conditions
hypovolemic shock
Beyond the preview
Go deeper on NCT04056065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04056065.